{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:16:18Z","timestamp":1790630178960,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We present two cases of Nodular Regenerative Hyperplasia (NRH) associated with Juvenile Dermatomyositis (JDM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case Presentation<\/jats:title>\n                <jats:p>Case 1: A nine-year-old Caucasian male with refractory JDM and anti-NXP2 autoantibodies was diagnosed at age two. Over seven years, he developed arthritis, dysphagia, dysphonia, severe calcinosis, and colitis. Complications included recurrent cellulitis, infections, and hepatosplenomegaly. Multiple medications were chronically used, including prednisone, methotrexate, azathioprine, cyclophosphamide, mycophenolate mofetil, rituximab, tacrolimus, etanercept, abatacept, infliximab, and tocilizumab.<\/jats:p>\n                <jats:p>Case 2: A 19-year-old Asian female with chronically active JDM and anti-MDA5 autoantibodies was diagnosed at age 15. Symptomatology included ulcerative skin lesions, Raynaud\u2019s phenomenon with digital ulcers, arthritis, interstitial lung disease with pulmonary hypertension, and calcinosis. Medications included chronic use of prednisone, methotrexate, abatacept, cyclophosphamide, mycophenolate mofetil, rituximab, tofacitinib, and sildenafil.<\/jats:p>\n                <jats:p>In both patients, clinical symptomatology was not suggestive of liver disease or portal hypertension, but laboratory studies revealed elevated serum transaminases with progressive thrombocytopenia and no active liver-associated infections. The first patient\u2019s liver ultrasound showed coarse hepatic texture with mild echogenicity, splenomegaly, and portal hypertension. The second patient\u2019s liver ultrasound was normal, but elastography indicated increased stiffness. Liver biopsy confirmed NRH in both patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is difficult to recognize NRH in JDM, as it often presents with elevated transaminases which may be mistaken for JDM muscle flare, corticosteroid-related fatty liver, or medication-related transaminitis. NRH has been associated with several medications used to treat JDM, including methotrexate, azathioprine, and cyclophosphamide, which should be discontinued if NRH develops. Providers should consider NRH in JDM patients with severe, refractory disease who have persistently elevated transaminases and persistent thrombocytopenia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00690-x","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T15:03:33Z","timestamp":1650467013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-6481","authenticated-orcid":false,"given":"Aviya","family":"Lanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Volochayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Vittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"690_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152833","author":"N Bakshi","year":"2020","unstructured":"Bakshi N, Gulati N, Rastogi A, Chougule A, Bihari C, Jindal A. Nodular regenerative hyperplasia: An under-recognized vascular disorder of liver. IJPRP. 2020. https:\/\/doi.org\/10.1016\/j.prp.2020.152833.","journal-title":"IJPRP"},{"issue":"1","key":"690_CR2","first-page":"7","volume":"44","author":"PA Reshamwala","year":"2006","unstructured":"Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: Not all nodules are created equal. Persp Clin Hepatol. 2006;44(1):7\u201314.","journal-title":"Persp Clin Hepatol"},{"key":"690_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1078\/0171-2985-00209","volume":"207","author":"R Klein","year":"2003","unstructured":"Klein R, Goller S, Bianchi L. Nodular regenerative hyperplasia of the liver: A manifestation of organ-specific antiphospholipid syndrome? Immunobiol. 2003;207:51\u20137.","journal-title":"Immunobiol"},{"issue":"11","key":"690_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","volume":"17","author":"M Hartleb","year":"2011","unstructured":"Hartleb M, Gutkowski K, Milkiewicz P. Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol. 2011;17(11):1400\u20139.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"690_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/1529-0131(200105)44:5<1139::AID-ANR195>3.0.CO;2-M","volume":"44","author":"RA Russo","year":"2001","unstructured":"Russo RA, Katsicas MM, Davila M, Ciocca M, Zelazko M. Cholestasis in juvenile dermatomyositis: Report of three cases. Arthr & Rheumatism. 2001;44(5):1139\u201342.","journal-title":"Arthr & Rheumatism"},{"key":"690_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0034-1375963","volume":"34","author":"M Ghabril","year":"2014","unstructured":"Ghabril M, Vuppalanchi R. Drug-induced nodular regenerative hyperplasia. Semin Liver Dis. 2014;34:240\u20135.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"690_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5114\/reum.2020.99782","volume":"58","author":"J Podgorska","year":"2020","unstructured":"Podgorska J, Werel P, Klapaczynski J, Orzechowska D, Wudarski M, Gietka A. Liver involvement in rheumatic diseases. Rheumatoligia. 2020;58(5):289\u201396.","journal-title":"Rheumatoligia"},{"key":"690_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1034\/j.1600-0676.2000.020005366.x","volume":"20","author":"T Matsumoto","year":"2000","unstructured":"Matsumoto T, et al. The liver in collagen disease: Pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia. Liver. 2000;20:366\u201373.","journal-title":"Liver"},{"issue":"4","key":"690_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","volume":"33","author":"IJ Fuss","year":"2013","unstructured":"Fuss IJ, Friend J, Yang Z, He P, Hooda L, Boyer J, Xi L, Raffeld M, Kleiner D, Heller T, Strober W. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol. 2013;33(4):748\u201358.","journal-title":"J Clin Immunol"},{"issue":"4","key":"690_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","volume":"14","author":"TL Wampler Muskardin","year":"2018","unstructured":"Wampler Muskardin TL, Jiewold TB. Type I interferon in rheumatic diseases. Nat Rev Rheumatol. 2018;14(4):214\u201328.","journal-title":"Nat Rev Rheumatol"},{"key":"690_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apt.12490","volume":"38","author":"CO Musumba","year":"2013","unstructured":"Musumba CO. Review article: The association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy. Aliment Pharmacol Ther. 2013;38:1025\u201337.","journal-title":"Aliment Pharmacol Ther"},{"key":"690_CR12","first-page":"40","volume":"46","author":"T Wada","year":"2016","unstructured":"Wada T, Abe G, Kudou T, Ogawa E, Nagai T, Tanaka S, Hirohata S. Liver damage in patients with polymyositis and dermatomyositis. Kitasato Med J. 2016;46:40\u20136.","journal-title":"Kitasato Med J"},{"issue":"6","key":"690_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0046-8177(88)80180-1","volume":"19","author":"C Yutani","year":"1988","unstructured":"Yutani C, Imakita M, Ishibashi-Ueda H, Okubo S, Naito M, Kunieda T. Nodular regenerative hyperplasia of the liver associated with primary pulmonary hypertension. Human Path. 1988;19(6):726\u201331.","journal-title":"Human Path"},{"issue":"3","key":"690_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/hep.31775","volume":"74","author":"J Hercun","year":"2021","unstructured":"Hercun J, Parikh E, Kleiner DE, Fuss I, Uzel G, Strober W, Koh C, Holland SM, Heller T. Recurrent nodular regenerative hyperplasia following liver transplantation in common variable immunodeficiency. Hepatol. 2021;74(3):1698\u2013701. https:\/\/doi.org\/10.1002\/hep.31775 Epub 2021 Aug 26. PMID 33638875; PMCID: PMC8390566.","journal-title":"Hepatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00690-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00690-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T13:14:35Z","timestamp":1650546875000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00690-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["690"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00690-x","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current case report was approved as part of the myositis natural history protocol (94-E-0165) by the NIH ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the patients prior to publication, using the study consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}